Reply to "Phase II prospective randomized trial of weight loss prior to radical prostatectomy"

W Demark-Wahnefried; S Rais-Bahrami; R A Desmond; J B Gordetsky; M Azrad; A D Frugé; E S Yang; L A Norian; W E Grizzle

doi:10.1038/s41391-018-0038-9

Reply to "Phase II prospective randomized trial of weight loss prior to radical prostatectomy"

Prostate Cancer Prostatic Dis. 2018 Jun;21(2):293-294. doi: 10.1038/s41391-018-0038-9. Epub 2018 Apr 24.

Authors

W Demark-Wahnefried^{1

2}, S Rais-Bahrami^{3

4

5}, R A Desmond^{3

6}, J B Gordetsky^{3

4

7}, M Azrad⁸, A D Frugé⁸, E S Yang^{3

9}, L A Norian^{8

3}, W E Grizzle^{3

7}

Affiliations

¹ Department of Nutrition Sciences, University of Alabama at Birmingham (UAB), Birmingham, AL, USA. demark@uab.edu.
² UAB Comprehensive Cancer Center, Birmingham, AL, USA. demark@uab.edu.
³ UAB Comprehensive Cancer Center, Birmingham, AL, USA.
⁴ Department of Urology, UAB, Birmingham, AL, USA.
⁵ Department of Radiology, UAB, Birmingham, AL, USA.
⁶ Department of Preventive Medicine, UAB, Birmingham, AL, USA.
⁷ Department of Pathology, Division of Anatomic Pathology, UAB, Birmingham, AL, USA.
⁸ Department of Nutrition Sciences, University of Alabama at Birmingham (UAB), Birmingham, AL, USA.
⁹ Department of Radiation Oncology, UAB, Birmingham, AL, USA.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Humans
Male
Prospective Studies
Prostate-Specific Antigen
Prostatectomy
Prostatic Neoplasms / surgery*
Weight Loss*

Substances

Prostate-Specific Antigen